3rd Quarter - Report
BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY
Client
Income
—
Expenses
$210,000
Expense method
C: businesses, Internal Revenue Code section 162(e)
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
NIH Funding Global Health Funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANNY LY | — |
| TODD SPANGLER | — |
Medical/Disease Research/Clinical Labs MED
Issues related to device cybersecurity
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD SPANGLER | — |
Trade (domestic/foreign) TRD
India price controls
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD SPANGLER | — |
Taxation/Internal Revenue Code TAX
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSICA JOHNSTON | — |
| DANNY LY | — |
| TODD SPANGLER | — |
Health Issues HCR
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety H.R.2430, FDA Reauthorization Act of 2017, Medical device user fee agreement VA procurement
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSICA JOHNSTON | — |
| JENNIFER M LURAY | — |
| DANNY LY | — |
| TODD SPANGLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.